Brief: Moberg Pharma Q4 EBIT Loss of SEK 4.6 Million
Feb 7 (Reuters) - Moberg Pharma Q4 EPS SEK -0.03. * Q4 net income SEK -3.1 million * Q4 EBITDA SEK -3.9 million
Recent news on Moberg Pharma AB (publ)
See all newsSweden's Moberg Pharma Q2 loss narrows as revenue rises
Brief: Moberg Pharma Q2 EBITDA SEK -4.3 Million
Brief: Moberg Pharma Names Vaidrius Navikas Chief Medical Officer
Brief: Moberg Pharma And Karo Healthcare Expand Collaboration
Moberg Pharma Q1 revenue rises, losses narrow on Nordic market share gains